ScienceDaily (Apr. 12, 2010) — To prevent blood clots during therapeutic hypothermia, scientists have developed what may be the first drug activated by cool temperatures and turned off by warm ones, according to research presented at the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2010.